Sector: Healthcare · Industry: Drug Manufacturers - Specialty & Generic
ChengDu ShengNuo Biotec Co.,Ltd. engages in the research and development, production, sale, and export of peptide drugs. The company offers semaglutide, tirzepatide, retatrutide, cagrilintide, lanreotide, bivalirudin, epitifibatide, liraglutide; icatibant, octreotide, teriparatide, ziconotide, ganirelix, linaclotide, abaloparatide, terlipressin acetate; levosimendane, thymosin alpha, enfuvirtide, somatostatin, thymopentin, carbetocin, atosiban acetate, exenatide; and leuprorelin, degarelix, cetrorelix, plecanatide, and desmopressin acetate. ChengDu ShengNuo Biotec Co.,Ltd. was founded in 2001 and is based in Chengdu, China.
Headquarters: Chengdu · Employees: 1605 · Website: https://www.snbiopharm.com
MACMIC Science & Technology Co., Ltd. (688117.SS) is a publicly traded company in the Healthcare sector (Drug Manufacturers - Specialty & Generic). Macroplane maps its supply-chain relationships, suppliers, buyers, financial health, and competitive positioning.
Competitors of MACMIC Science & Technology Co., Ltd. (688117.SS) tracked by Macroplane include ALPHA & OMEGA SEMICONDUCTOR Ltd (AOSL), COHERENT CORP. (COHR), Fujikura Ltd. (6501.T), LITTELFUSE INC /DE (LFUS), MICROCHIP TECHNOLOGY INC (MCHP), Mitsubishi Electric Corporation (6503.T), ON SEMICONDUCTOR CORP (ON), Qorvo, Inc. (QRVO), and 4 more.
Search companies · Macro trends · Industries · Product categories · Baskets